Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Johan Vansteenkiste

Professor

Catholic University of Leuven

Belgium

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Pharmacotherapy

40%

Immunology

10%

Cancer Therapy

40%

Lung Cancer

20%

Oncology

20%

Cancer Biology

20%

Lung Disease

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles6

Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC

Article Link

Year:

2024

Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors

Article Link

Year:

2023

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Article Link

Year:

2022

Acquired resistance in NSCLC: the journey from clinical definition to molecular understanding

Article Link

Year:

2021

Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS data

Article Link

Year:

2021

A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non–Small Cell Lung Cancer

Article Link

Year:

2020

Collaborators4

Marina Garassino

Università degli Studi di Torino

ITALY

Els Wauters

Universitaire Ziekenhuizen Leuven

BELGIUM

Hans C. van Houwelingen

Professor Emeritus

LUMC

NETHERLANDS

Fariba Tohidinezhad

University of Maastricht

NETHERLANDS

How do I reach out?

Meet Kite AI